Ai-Qin Jiang

Ai-Qin Jiang

UNVERIFIED PROFILE

Are you Ai-Qin Jiang?   Register this Author

Register author
Ai-Qin Jiang

Ai-Qin Jiang

Publications by authors named "Ai-Qin Jiang"

Are you Ai-Qin Jiang?   Register this Author

10Publications

425Reads

31Profile Views

Synthesis, anticancer activity and molecular docking studies on 1,2-diarylbenzimidazole analogues as anti-tubulin agents.

Bioorg Chem 2019 Nov 26;92:103219. Epub 2019 Aug 26.

State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, People's Republic of China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bioorg.2019.103219DOI Listing
November 2019

A patent review of RAF kinase inhibitors (2010-2018).

Expert Opin Ther Pat 2019 Sep 6;29(9):675-688. Epub 2019 Aug 6.

State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University , Nanjing , People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543776.2019.1651842DOI Listing
September 2019

A class of novel tubulin polymerization inhibitors exert effective anti-tumor activity via mitotic catastrophe.

Eur J Med Chem 2019 Feb 17;163:896-910. Epub 2018 Dec 17.

State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, 210023, People's Republic of China. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S02235234183106
Publisher Site
http://dx.doi.org/10.1016/j.ejmech.2018.12.030DOI Listing
February 2019

FAK inhibitors in Cancer, a patent review.

Expert Opin Ther Pat 2018 02 13;28(2):139-145. Epub 2017 Dec 13.

a State Key Laboratory of Pharmaceutical Biotechnology , Nanjing University , Nanjing P. R. China.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/13543776.2018.1
Publisher Site
http://dx.doi.org/10.1080/13543776.2018.1414183DOI Listing
February 2018

Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.

Eur J Med Chem 2015 Apr 3;94:447-57. Epub 2015 Mar 3.

State Key Laboratory of Pharmaceutical Biotechnology, School of Life Science, Nanjing University, Nanjing 210093, PR China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2015.02.058DOI Listing
April 2015

Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.

Bioorg Med Chem Lett 2014 Nov;24(22):5279-83

State Key Laboratory of Pharmaceutical Biotechnology, School of Life Science Nanjing University, Nanjing 210093, People’s Republic of China.

View Article

Download full-text PDF

Source
November 2014

Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.

Bioorg Med Chem Lett 2014 Sep 28. Epub 2014 Sep 28.

State Key Laboratory of Pharmaceutical Biotechnology, School of Life Science Nanjing University, Nanjing 210093, People's Republic of China. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0960894X140100
Publisher Site
http://dx.doi.org/10.1016/j.bmcl.2014.09.054DOI Listing
September 2014

Synthesis, biological evaluation and molecular modeling of 1,3,4-thiadiazol-2-amide derivatives as novel antitubulin agents.

Bioorg Med Chem 2014 Aug 17;22(15):4312-22. Epub 2014 May 17.

State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, PR China; School of Medicine, Nanjing University, Nanjing 210093, PR China. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09680896140036
Publisher Site
http://dx.doi.org/10.1016/j.bmc.2014.05.017DOI Listing
August 2014

Synthesis, biological evaluation, and molecular docking studies of novel 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety as FAK inhibitors with anticancer activity.

Bioorg Med Chem 2014 Jun 13;22(11):2947-54. Epub 2014 Apr 13.

State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, People's Republic of China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2014.04.005DOI Listing
June 2014

Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.

Bioorg Med Chem 2013 Jul 23;21(13):3723-9. Epub 2013 Apr 23.

State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2013.04.043DOI Listing
July 2013